Sepragen along with SUNY, Albany win NIIMBL grant for “Novel Bioreactor for hematopoietic cell expansion.
Sepragen wins NIIMBL grant
Sepragen along with SUNY, Albany win NIIMBL grant for “Novel Bioreactor for hematopoietic cell expansion.
Author: daniel
Sepragen wins NIIMBL award
Sepragen wins NIIMBL award for “Rapid Continuous Production of Room Temperature Stable mRNA vaccines.
Sepragen wins NIIMBL award for “Rapid Continuous Production of Room Temperature Stable mRNA vaccines.
Sepragen ships Custom Chromatography Systems
Sepragen ships two, 125 LPM Custom Chromatography Systems with inline integrated Buffer Blending Capability for Covid-19 vaccine production in 14 weeks to enable ramp from 40M doses to 200M doses/ month.
Sepragen ships two, 125 LPM Custom Chromatography Systems with inline integrated Buffer Blending Capability for Covid-19 vaccine production in 14 weeks to enable ramp from 40M doses to 200M doses/ month.
Sepragen partners with I&L Biosystems
Sepragen partners with I&L Biosystems to distribute it’s products in Europe.
Sepragen partners with I&L Biosystems to distribute it’s products in Europe.
Sepragen published in GEN magazine
Sepragen article on “Single Use Chromatography Systems” published in GEN magazine.
Sepragen article on “Single Use Chromatography Systems” published in GEN magazine.
Sepragen ships Continuous Two column Capture system
Sepragen ships Continuous Two column Capture system with Buffer Blending Capability and Continuous multi-unit operation “Flow thru” skid for 200DL Perfusion Scale.
Sepragen ships Continuous Two column Capture system with Buffer Blending Capability and Continuous multi-unit operation “Flow thru” skid for 200DL Perfusion Scale.
